Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genvoya vs Stribild in Treatment-Naïve HIV-1 Adults
NCT01780506Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of tenofovir alafenamide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Dec 2012; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01780506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780506.